Method to treat patients with amyotrophic lateral sclerosis and the like
OwnerRoberta Nora Malone Rooneyinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerRoberta Nora Malone Rooneyinventor
Estimating the term…
The hepatically produced isomers, URO I and URO III, are neuroprotectors capable of halting or mitigating the nervous system destruction in common neurological disorders. URO I protects neurons of the central nervous system from damage that would otherwise ensue from the neurotoxicity associated with the hepatic heme porphyrin precursors, delta-aminolevulinic acid and porphobilinogen. A method is disclosed to increase URO I to treat amyotrophic lateral sclerosis (ALS), stroke, encephalitis, meningitis, spinal cord injury and hereditary biochemical multiple sclerosis. Increases of URO III are also used to protect neurons in the peripheral nervous system in disorders including acute immunodeficiency syndrome (AIDS) related neuropathy, Guillaine-Barre syndrome and diabetic neuropathy.
A method of treatment for common neurological disorders of the central and peripheral nervous systems wherein the neuron damage associated with the porphyrin precursors, delta-aminolevulinic acid and/or porphobilinogen, is a contributing factor, comprising the use of a uroporphyrin isomer as a neuroprotector to halt or mitigate the neuron damage.
Dependencies are inferred from the claim text.